Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Repare Therapeutics Inc. (RPTX) had Return on Tangible Equity of -15.17% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.25M |
|
$-16.74M |
|
-- |
|
$0.25M |
|
$18.03M |
|
$-17.78M |
|
$1.28M |
|
$-16.50M |
|
$-16.50M |
|
$-16.74M |
|
$-16.74M |
|
$-16.74M |
|
$-16.74M |
|
$-17.78M |
|
$-17.22M |
|
42.92M |
|
42.92M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$126.57M |
|
$0.07M |
|
$3.92M |
|
$130.49M |
|
$20.09M |
|
-- |
|
-- |
|
$20.09M |
|
$110.41M |
|
$110.41M |
|
$110.41M |
|
42.96M |
|
| Cash Flow Statement Financials | |
$-45.48M |
|
$28.21M |
|
$0.08M |
|
$84.72M |
|
$67.66M |
|
$-17.06M |
|
$6.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-7112.00% |
|
-7112.00% |
|
-- |
|
-6598.40% |
|
-6697.60% |
|
$-44.48M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.02 |
|
5262.84 |
|
-15.17% |
|
|
Return on Tangible Equity |
-15.17% |
-12.83% |
|
-15.17% |
|
$2.57 |
|
$-1.04 |
|
$-1.06 |
|